Wolfang Lagraf
Aims: To examine the outcomes of the treatment with insulin glargine 100 U/mL (IGlar-100) in newly identified subgroups of type 2 diabetes mellitus (T2DM).
..Veja mais»Margarita E Matte and Emmanuel G Velonakis
Type 2 diabetes is the most costly chronic disease for both, the individual and the society. Many randomized controlled trials of structured lifestyle modification have consiste..Veja mais»
Dhruv K Singh and Ken Farrington
Vascular calcification contributes significantly to the vascular damage burden in type 2 diabetes. Chronic hyperglycaemia is the driver of initiation and progre..Veja mais»
Sameena Iqbal and Ahsan Alam
Diabetic kidney disease is the predominant cause of end stage kidney disease in North America, estimated to be 152 per million population in 2010. New guideline..Veja mais»
Alain Tenenbaum
The immediate non invasive true medical face lifts using muscular repositioning without volume augmentation by myoplasty, myopexy and myotension (called Endopeel techniques) is ..Veja mais»
E. Premprakash Patra, Dayanidhi Meher, Mrutyunjay Suar, Jyoti Panigrahi and Srilekha Mishra
Bacteremia in Type 2 Diabetes (T2D) is the most serious public health issue. Very limited information is available in this aspect with reference to complications. We hypothesize..Veja mais»